News & Updates

Product Highlight - Fosphenytoin sodium (Aurantin)

31 Aug 2023

Fosphenytoin sodium (Aurantin) - Soln for inj (vial) 75 mg/mL

Product Highlight - Fosphenytoin sodium (Aurantin)

31 Aug 2023

Product Highlight - KANJINTI

31 Aug 2023

Trastuzumab Powd for conc for soln for infusion 150 mg

Product Highlight - KANJINTI

31 Aug 2023

Product Highlight - NEOPRED

31 Aug 2023

Prednisolone tablet 5 mg & 20 mg, syr 20 mg/5 mL

Product Highlight - NEOPRED

31 Aug 2023

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

31 Aug 2023

Paracetamol + Orphenadrine Citrate 450 mg/35 mg FC tab and 650 mg/35 mg FC tab (Forte)

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

31 Aug 2023

Product Highlight - MEPRESONE 40

31 Aug 2023

Methylprednisolone 40 mg powd for inj

Product Highlight - MEPRESONE 40

31 Aug 2023

Jakinibs for AD in Asians: Is one better than the other?

31 Aug 2023 by

Treatment with oral Janus kinase (JAK) inhibitors or jakinibs appeared well tolerated in patients with atopic dermatitis (AD) as shown in an Asian retrospective cohort study.

Jakinibs for AD in Asians: Is one better than the other?

31 Aug 2023

Statin cuts CV risk in patients with HIV

31 Aug 2023 by

Treatment with pitavastatin is associated with a significantly lower risk of cardiovascular (CV) events in people living with human immunodeficiency virus (HIV) as shown in the final analysis of the double-blind, placebo-controlled REPRIEVE trial presented at IAS 2023.

Statin cuts CV risk in patients with HIV

31 Aug 2023

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

30 Aug 2023 by

Treatment with nirmatrelvir plus ritonavir appears to reduce the incidence of hospitalization in a highly vaccinated population of high-risk COVID-19 patients in Malaysia, as shown in a study.

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

30 Aug 2023

Does misoprostol reduce risk of NSAID-induced kidney injury?

30 Aug 2023

Misoprostol, a prostaglandin E1 analogue used to prevent nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal disorders, appears effective in preventing kidney injury associated with chronic NSAID use, but the quality of evidence is very low, results of a recent study have shown.

Does misoprostol reduce risk of NSAID-induced kidney injury?

30 Aug 2023

Do weak opioids increase risk of GI cancers?

30 Aug 2023 by

Evidence on the association of weak opioids with a higher risk of oesophageal and colorectal cancer is not reliable, but there appears to be a small association with gastric cancer, suggests a study.

Do weak opioids increase risk of GI cancers?

30 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Product Highlight - Fosphenytoin sodium (Aurantin)

Product Highlight - Fosphenytoin sodium (Aurantin)

Product Highlight - KANJINTI

Product Highlight - KANJINTI

Product Highlight - NEOPRED

Product Highlight - NEOPRED

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

Product Highlight - MEPRESONE 40

Product Highlight - MEPRESONE 40

Jakinibs for AD in Asians: Is one better than the other?

Jakinibs for AD in Asians: Is one better than the other?

Statin cuts CV risk in patients with HIV

Statin cuts CV risk in patients with HIV

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

Does misoprostol reduce risk of NSAID-induced kidney injury?

Does misoprostol reduce risk of NSAID-induced kidney injury?

Do weak opioids increase risk of GI cancers?

Do weak opioids increase risk of GI cancers?